Innovation1 Biotech Stock Price Prediction
| IVBT Stock | USD 0 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Innovation1 Biotech hype-based prediction, you can estimate the value of Innovation1 Biotech from the perspective of Innovation1 Biotech response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Innovation1 Biotech. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Innovation1 Biotech to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Innovation1 because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Innovation1 Biotech after-hype prediction price | USD 0.001 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Innovation1 |
Innovation1 Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Innovation1 Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Innovation1 Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Innovation1 Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Innovation1 Biotech Estimiated After-Hype Price Volatility
In the context of predicting Innovation1 Biotech's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Innovation1 Biotech's historical news coverage. Innovation1 Biotech's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Innovation1 Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Innovation1 Biotech is very steady at this time. Analysis and calculation of next after-hype price of Innovation1 Biotech is based on 3 months time horizon.
Innovation1 Biotech OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Innovation1 Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Innovation1 Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Innovation1 Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 4 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0 | 0.00 |
|
Innovation1 Biotech Hype Timeline
Innovation1 Biotech is currently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Innovation1 is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Innovation1 Biotech is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 75.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innovation1 Biotech recorded earning per share (EPS) of 5.54. The entity last dividend was issued on the 12th of January 2021. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Innovation1 Biotech Basic Forecasting Models to cross-verify your projections.Innovation1 Biotech Related Hype Analysis
Having access to credible news sources related to Innovation1 Biotech's direct competition is more important than ever and may enhance your ability to predict Innovation1 Biotech's future price movements. Getting to know how Innovation1 Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Innovation1 Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AKESF | Akeso, Inc | 0.00 | 0 per month | 3.85 | 0.10 | 12.00 | (7.89) | 41.83 | |
| ADYX | Adynxx Inc | 0.00 | 0 per month | 0.00 | 0.03 | 0.00 | 0.00 | 266.67 | |
| ASCLF | Ascletis Pharma | 0.00 | 0 per month | 0.00 | 0.06 | 0.00 | 0.00 | 33.04 | |
| AVXT | Avax Techs | 0.00 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWBR | CohBar Inc | 0.07 | 3 per month | 5.34 | 0.08 | 5.73 | (5.59) | 250.97 | |
| OCEA | Ocean Biomedical | 0.02 | 3 per month | 0.00 | (0.13) | 7.46 | (6.93) | 28.33 | |
| ELEV | Elevation Oncology | 0.01 | 10 per month | 0.00 | (0.10) | 5.77 | (8.22) | 22.21 | |
| AVRO | AVROBIO | 0.05 | 5 per month | 1.89 | 0.01 | 4.11 | (3.17) | 14.20 | |
| ZURA | Zura Bio Limited | (0.08) | 10 per month | 0.00 | (0.04) | 8.08 | (7.94) | 30.69 |
Innovation1 Biotech Additional Predictive Modules
Most predictive techniques to examine Innovation1 price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Innovation1 using various technical indicators. When you analyze Innovation1 charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Innovation1 Biotech Predictive Indicators
The successful prediction of Innovation1 Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Innovation1 Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Innovation1 Biotech based on analysis of Innovation1 Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Innovation1 Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Innovation1 Biotech's related companies.
Story Coverage note for Innovation1 Biotech
The number of cover stories for Innovation1 Biotech depends on current market conditions and Innovation1 Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Innovation1 Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Innovation1 Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Innovation1 Biotech Short Properties
Innovation1 Biotech's future price predictability will typically decrease when Innovation1 Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Innovation1 Biotech often depends not only on the future outlook of the potential Innovation1 Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Innovation1 Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20 M | |
| Short Long Term Debt | 10000.00 | |
| Shares Float | 2 M |
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.